(Q39013884)

8 September 2017

PKA/AMPK signaling in relation to adiponectin's antiproliferative effect on multiple myeloma cells (English)

1 reference

8 September 2017

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24646889%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

E A Medina

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24646889%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

K Oberheu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24646889%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

V Ortega

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24646889%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

G V N Velagaleti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24646889%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

B O Oyajobi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24646889%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

20 March 2014

1 reference

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24646889%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24646889%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24646889%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

2080-2089

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24646889%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2014.112

10 June 2020

exact match

0 references

cites work

Anthropometric characteristics and risk of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Adipokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Adiponectin receptor as a key player in healthy longevity and obesity-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

The role of adiponectin in cancer: a review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

A prospective study of circulating adipokine levels and risk of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

APPL1: role in adiponectin signaling and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

The AMP-activated protein kinase--fuel gauge of the mammalian cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Activation of cyclic-AMP response element binding protein contributes to adiponectin-stimulated interleukin-10 expression in RAW 264.7 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Beta-adrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

cAMP inhibition of Akt is mediated by activated and phosphorylated Rap1b

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Increased lipogenesis in cancer cells: new players, novel targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Physiological regulation of acetyl-CoA carboxylase gene expression: effects of diet, diabetes, and lactation on acetyl-CoA carboxylase mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Inhibition of fatty acid metabolism reduces human myeloma cells proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Activation of AMPK by pterostilbene suppresses lipogenesis and cell-cycle progression in p53 positive and negative human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

PI3K/Akt pathway mediates high glucose-induced lipid accumulation in human renal proximal tubular cells via spliced XBP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Obesity and free fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells

21 January 2018

1 reference

12 December 2020

Acetyl coenzyme A carboxylase

1 reference

12 December 2020

Inhibition of fatty acid synthesis in isolated adipocytes by 5-(tetradecyloxy)-2-furoic acid

1 reference

12 December 2020

Mechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis

1 reference

12 December 2020

Critical phosphorylation sites for acetyl-CoA carboxylase activity.

1 reference

12 December 2020

1 reference

12 December 2020

PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP.

1 reference

12 December 2020

Mechanisms underlying the anti-proliferative actions of adiponectin in human breast cancer cells, MCF7-dependency on the cAMP/protein kinase-A pathway

1 reference

12 December 2020

Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.112

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/LEU.2014.112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24646889%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24646889%20AND%20SRC:MED&resulttype=core&format=json